Bitcoin

This represents the first concrete validation of AI's life sciences potential since the 2023-24 AI token bubble burst, contrasting sharply with failed 'AI for crypto' projects. It highlights a dangerous divergence where AI's real-world impact grows while crypto's AI narrative remains speculative, risking permanent capital reallocation from crypto to traditional biotech investments.

Layla Hosseini-Gerami announced a method using AI to repurpose failed drugs into new medicines.